QA: GALECTIN THERAPEUTICS INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001133416_2023_GALECTIN_THERAPEUTICS_INC.pdf

Logs

Graph

Absolute values for 0001133416, GALECTIN THERAPEUTICS INC

  xvar xval
0 AssetsCurrent 20,552,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 733,000
4 LiabilitiesCurrent 13,012,000
5 LiabilitiesNoncurrent 66,000
6 remainder_Liabilities 40,401,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,615,000
9 ResearchAndDevelopmentExpense 31,737,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -424,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 21,285,000
1 Liabilities 53,479,000
2 Expenses 38,352,000
3 Revenues 0
4 StockholdersEquity -32,194,000
5 NetIncome -38,776,000
6 ComprehensiveNetIncome -38,776,000
7 BaseVar 56,770,000
8 EconomicCapitalRatio -2.52

Edgar->Model Mapping

Feature Distribution

Change over Time